Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 28
Filter
1.
Cereb Cortex ; 30(4): 2229-2249, 2020 04 14.
Article in English | MEDLINE | ID: mdl-33676371

ABSTRACT

Genetically distinct GABAergic interneuron subtypes play diverse roles in cortical circuits. Previous studies revealed that microRNAs (miRNAs) are differentially expressed in cortical interneuron subtypes, and are essential for the normal migration, maturation, and survival of medial ganglionic eminence-derived interneuron subtypes. How miRNAs function in vasoactive intestinal peptide expressing (VIP+) interneurons derived from the caudal ganglionic eminence remains elusive. Here, we conditionally removed Dicer in postmitotic VIP+ interneurons to block miRNA biogenesis. We found that the intrinsic and synaptic properties of VIP+ interneurons and pyramidal neurons were concordantly affected prior to a progressive loss of VIP+ interneurons. In vivo recording further revealed elevated cortical local field potential power. Mutant mice had a shorter life span but exhibited better spatial working memory and motor coordination. Our results demonstrate that miRNAs are indispensable for the function and survival of VIP+ interneurons, and highlight a key role of VIP+ interneurons in cortical circuits.


Subject(s)
Cerebral Cortex/metabolism , Interneurons/metabolism , MicroRNAs/antagonists & inhibitors , Nerve Net/metabolism , Vasoactive Intestinal Peptide/deficiency , Animals , Cerebral Cortex/growth & development , Male , Maze Learning/physiology , Mice , Mice, Transgenic , MicroRNAs/genetics , Nerve Net/growth & development , Vasoactive Intestinal Peptide/genetics
2.
Neuroimmunomodulation ; 22(3): 203-12, 2015.
Article in English | MEDLINE | ID: mdl-25301381

ABSTRACT

OBJECTIVES: Vasoactive intestinal peptide (VIP) is an immunomodulatory neuropeptide with therapeutic properties in multiple murine models of inflammatory disease including the trinitrobenzene-sulfonic acid (TNBS)-colitis model of Crohn's disease. Understanding the spectrum of biological actions of endogenously produced VIP may help us dissect the complex and multifactorial pathogenesis of such inflammatory diseases. Our goal was to determine the contribution of endogenously produced VIP to TNBS-colitis by using VIP knockout (KO) mice. METHODS: TNBS was intracolonically administered to wild-type (WT) and VIP KO mice, and weight loss and colitis were assessed over time. Colon histopathological changes and myeloperoxidase activities were analyzed and the levels of tumor necrosis factor (TNF)-α and interleukin (IL)-6 in colon and serum quantified. The proliferative response in vitro of splenocytes from TNBS WT and VIP KO administered mice to anti-CD3 and anti-CD28 was determined. RESULTS: VIP KO mice did not exhibit the predicted exacerbated response to TNBS. Instead, they developed a milder clinical profile than WT mice, with lower TNF-α and IL-6 levels. Such potential defects seem selective, because other parameters such as the histopathological scores and the cytokine levels in the colon did not differ between the two strains of mice. Moreover, splenocytes from TNBS-treated VIP KO mice exhibited an enhanced proliferative response to anti-CD3/CD28 stimulation in vitro. CONCLUSION: Chronic loss of VIP in mice leads to a disruption of certain but not all immunological compartments, corroborating recent findings that VIP KO mice exhibit reduced mortality in the lipopolysaccharide-induced endotoxemia model and attenuated clinical development of experimental autoimmune encephalomyelitis while developing robust T-cell responses.


Subject(s)
Colitis/chemically induced , Colitis/pathology , Colon/pathology , Trinitrobenzenesulfonic Acid/toxicity , Vasoactive Intestinal Peptide/deficiency , Animals , Cell Proliferation/drug effects , Cell Proliferation/genetics , Colon/metabolism , Cytokines/genetics , Cytokines/metabolism , Disease Models, Animal , Enzyme-Linked Immunosorbent Assay , Gene Expression Regulation/genetics , Mice , Mice, Inbred C57BL , Mice, Knockout , Peroxidase/metabolism , RNA, Messenger/metabolism , T-Lymphocytes/drug effects , T-Lymphocytes/metabolism , Time Factors , Vasoactive Intestinal Peptide/genetics
3.
Proc Natl Acad Sci U S A ; 108(34): 14306-11, 2011 Aug 23.
Article in English | MEDLINE | ID: mdl-21788520

ABSTRACT

The suprachiasmatic nucleus (SCN) is the principal circadian pacemaker of mammals, coordinating daily rhythms of behavior and metabolism. Circadian timekeeping in SCN neurons revolves around transcriptional/posttranslational feedback loops, in which Period (Per) and Cryptochrome (Cry) genes are negatively regulated by their protein products. Recent studies have revealed, however, that these "core loops" also rely upon cytosolic and circuit-level properties for sustained oscillation. To characterize interneuronal signals responsible for robust pacemaking in SCN cells and circuits, we have developed a unique coculture technique using wild-type (WT) "graft" SCN to drive pacemaking (reported by PER2::LUCIFERASE bioluminescence) in "host" SCN deficient either in elements of neuropeptidergic signaling or in elements of the core feedback loop. We demonstrate that paracrine signaling is sufficient to restore cellular synchrony and amplitude of pacemaking in SCN circuits lacking vasoactive intestinal peptide (VIP). By using grafts with mutant circadian periods we show that pacemaking in the host SCN is specified by the genotype of the graft, confirming graft-derived factors as determinants of the host rhythm. By combining pharmacological with genetic manipulations, we show that a hierarchy of neuropeptidergic signals underpins this paracrine regulation, with a preeminent role for VIP augmented by contributions from arginine vasopressin (AVP) and gastrin-releasing peptide (GRP). Finally, we show that interneuronal signaling is sufficiently powerful to maintain circadian pacemaking in arrhythmic Cry-null SCN, deficient in essential elements of the transcriptional negative feedback loops. Thus, a hierarchy of paracrine neuropeptidergic signals determines cell- and circuit-level circadian pacemaking in the SCN.


Subject(s)
Circadian Rhythm/physiology , Nerve Net/metabolism , Paracrine Communication , Signal Transduction , Suprachiasmatic Nucleus/metabolism , Animals , Circadian Rhythm/genetics , Coculture Techniques , Cryptochromes/deficiency , Cryptochromes/metabolism , Gene Expression Regulation , Mice , Paracrine Communication/genetics , Receptors, Vasoactive Intestinal Peptide, Type II/deficiency , Receptors, Vasoactive Intestinal Peptide, Type II/metabolism , Signal Transduction/genetics , Suprachiasmatic Nucleus/cytology , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/metabolism
4.
J Immunol ; 187(2): 1057-65, 2011 Jul 15.
Article in English | MEDLINE | ID: mdl-21677142

ABSTRACT

Vasoactive intestinal peptide (VIP) induces regulatory dendritic cells (DC) in vitro that inhibit cellular immune responses. We tested the role of physiological levels of VIP on immune responses to murine CMV (mCMV) using VIP-knockout (VIP-KO) mice and radiation chimeras engrafted with syngenic VIP-KO hematopoietic cells. VIP-KO mice had less weight loss and better survival following mCMV infection compared with wild-type (WT) littermates. mCMV-infected VIP-KO mice had lower viral loads, faster clearance of virus, with increased numbers of IFN-γ(+) NK and NKT cells, and enhanced cytolytic activity of NK cells. Adaptive antiviral cellular immunity was increased in mCMV-infected VIP-KO mice compared with WT mice, with more Th1/Tc1-polarized T cells, fewer IL-10(+) T cells, and more mCMV-M45 epitope peptide MHC class I tetramer(+) CD8(+) T cells (tetramer(+) CD8 T cells). mCMV-immune VIP-KO mice had enhanced ability to clear mCMV peptide-pulsed target cells in vivo. Enhanced antiviral immunity was also seen in WT transplant recipients engrafted with VIP-KO hematopoietic cells, indicating that VIP synthesized by neuronal cells did not suppress immune responses. Following mCMV infection there was a marked upregulation of MHC-II and CD80 costimulatory molecule expression on DC from VIP-KO mice compared with DC from WT mice, whereas programmed death-1 and programmed death ligand-1 expression were upregulated in activated CD8(+) T cells and DC, respectively, in WT mice, but not in VIP-KO mice. Because the absence of VIP in immune cells increased innate and adaptive antiviral immunity by altering costimulatory and coinhibitory pathways, selective targeting of VIP signaling represents an attractive therapeutic target to enhance antiviral immunity.


Subject(s)
Bone Marrow Transplantation/immunology , Cell Polarity/immunology , Hematopoietic Stem Cells/immunology , Herpesviridae Infections/immunology , Herpesviridae Infections/prevention & control , Muromegalovirus/immunology , Th1 Cells/immunology , Vasoactive Intestinal Peptide/deficiency , Animals , Bone Marrow Transplantation/pathology , Cell Polarity/genetics , Female , Hematopoietic Stem Cells/pathology , Immunity, Innate/genetics , Immunity, Innate/immunology , Immunization, Secondary , Immunophenotyping , Listeriosis/immunology , Listeriosis/pathology , Male , Mice , Mice, Congenic , Mice, Inbred C57BL , Mice, Knockout , Radiation Chimera , Th1 Cells/microbiology , Th1 Cells/virology , Vasoactive Intestinal Peptide/biosynthesis , Vasoactive Intestinal Peptide/genetics
5.
Proc Natl Acad Sci U S A ; 107(45): 19555-60, 2010 Nov 09.
Article in English | MEDLINE | ID: mdl-20978211

ABSTRACT

The neuropeptide vasoactive intestinal peptide (VIP) has been shown to inhibit macrophage proinflammatory actions, promote a positive Th2/Th1 balance, and stimulate regulatory T-cell production. The fact that this peptide is highly efficacious in animal models of inflammatory diseases such as collagen-induced arthritis and experimental autoimmune encephalomyelitis (EAE) suggests that the endogenous peptide might normally provide protection against such pathologies. We thus studied the response of VIP-deficient (i.e., VIP KO) mice to myelin oligodendrocyte protein-induced EAE. Surprisingly, VIP KO mice were almost completely resistant to EAE, with delayed onset and mild or absent clinical profile. Despite this, flow cytometric analyses and antigen-rechallenge experiments indicated that myelin oligodendrocyte protein-treated VIP KO mice exhibited robust Th1/Th17 cell inductions and antigen-specific proliferation and cytokine responses. Moreover, adoptive transfer of lymphocytes from immunized VIP KO mice to WT recipients resulted in full-blown EAE, supporting their encephalitogenic potential. In contrast, transfer of encephalitogenic WT cells to VIP KO hosts did not produce EAE, suggesting that loss of VIP specifically affected the effector phase of the disease. Histological analyses indicated that CD4 T cells entered the meningeal and perivascular areas of VIP-deficient mice, but that parenchymal infiltration was strongly impaired. Finally, VIP pretreatment of VIP KO mice before immunization was able to restore their sensitivity to EAE. These results indicate that VIP plays an unanticipated permissive and/or proinflammatory role in the propagation of the inflammatory response in the CNS, a finding with potential therapeutic relevance in autoimmune neuroinflammatory diseases such as multiple sclerosis.


Subject(s)
Cell Movement/immunology , Central Nervous System/immunology , Encephalomyelitis, Autoimmune, Experimental/immunology , T-Lymphocytes/immunology , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/immunology , Animals , Autoimmune Diseases/etiology , Cytokines/biosynthesis , Encephalomyelitis, Autoimmune, Experimental/chemically induced , Encephalomyelitis, Autoimmune, Experimental/etiology , Inflammation/etiology , Lymphocyte Activation , Mice , Mice, Knockout , Myelin-Associated Glycoprotein/pharmacology , Th1 Cells , Th17 Cells
6.
Eur J Neurosci ; 35(9): 1466-74, 2012 May.
Article in English | MEDLINE | ID: mdl-22512278

ABSTRACT

The neuropeptide vasoactive intestinal peptide (VIP) is critical for the proper functioning of the neural circuit that generates circadian rhythms. Mice lacking VIP show profound deficits in the ability to generate many behavioral and physiological rhythms. To explore how the loss of VIP impacts on the intact circadian system, we carried out in vivo multiunit neural activity (MUA) recordings from the suprachiasmatic nucleus of freely moving VIP knockout (KO) mice. The MUA rhythms were largely unaltered in the VIP KO mice, with no significant differences being seen in the amplitude or phase of the rhythms in light-dark conditions. Robust differences between the genotypes were revealed when the mice were transferred from light-dark to constant darkness conditions. In addition, the ability of the VIP KO mice to encode changes in photoperiod was examined. Strikingly, the behavioral and physiological rhythms of VIP KO mice showed no adaptation to short or long photoperiods. The data indicate that the intact circadian system can compensate for some of the consequences of the loss of VIP, whereas this peptide is indispensable for endogenous encoding of seasonal information.


Subject(s)
Action Potentials/physiology , Circadian Rhythm/genetics , Circadian Rhythm/physiology , Photoperiod , Suprachiasmatic Nucleus/physiology , Action Potentials/genetics , Animals , Electrodes, Implanted , Male , Mice , Mice, Knockout , Motor Activity/genetics , Statistics, Nonparametric , Time Factors , Vasoactive Intestinal Peptide/deficiency , Wakefulness/genetics , Wakefulness/physiology
7.
J Neurosci ; 29(6): 1670-6, 2009 Feb 11.
Article in English | MEDLINE | ID: mdl-19211874

ABSTRACT

Mammalian circadian rhythms are orchestrated by the suprachiasmatic nuclei (SCN) of the hypothalamus. The SCN are composed of circadian clock neurons, but the mechanisms by which these populations of neuronal oscillators encode rhythmic behavior are incompletely understood. We have used ex vivo real-time gene expression imaging of the neural correlates of circadian behavior, combined with genetic disruption of vasoactive intestinal polypeptide, a key SCN signaling molecule, to examine the neural basis of circadian organization in the SCN. We show that the coherence and timing of clock neuron rhythms are correlated with the coherence and timing of behavioral rhythms within individual mice and that the degree of disruption of SCN neuronal organization correlates with the degree of behavioral disruption within individuals. Our results suggest that the SCN encode circadian phase as a temporal population vector of its constituent neurons; such that as the neuronal population becomes desynchronized, phase information becomes ambiguous.


Subject(s)
Biological Clocks/physiology , Circadian Rhythm/physiology , Nerve Net/physiology , Neurons/physiology , Animals , Male , Mice , Mice, Knockout , Mice, Transgenic , Nerve Net/cytology , Neurons/cytology , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/physiology
8.
Circulation ; 115(10): 1260-8, 2007 Mar 13.
Article in English | MEDLINE | ID: mdl-17309917

ABSTRACT

BACKGROUND: Vasoactive intestinal peptide (VIP), a pulmonary vasodilator and inhibitor of vascular smooth muscle proliferation, has been reported absent in pulmonary arteries from patients with idiopathic pulmonary arterial hypertension (PAH). We have tested the hypothesis that targeted deletion of the VIP gene may lead to PAH with pulmonary vascular remodeling. METHODS AND RESULTS: We examined VIP knockout (VIP-/-) mice for evidence of PAH, right ventricular (RV) hypertrophy, and pulmonary vascular remodeling. Relative to wild-type control mice, VIP-/- mice showed moderate RV hypertension, RV hypertrophy confirmed by increased ratio of RV to left ventricle plus septum weight, and enlarged, thickened pulmonary artery and smaller branches with increased muscularization and narrowed lumen. Lung sections also showed perivascular inflammatory cell infiltrates. No systemic hypertension and no arterial hypoxemia existed to explain the PAH. The condition was associated with increased mortality. Both the vascular remodeling and RV remodeling were attenuated after a 4-week treatment with VIP. CONCLUSIONS: Deletion of the VIP gene leads to spontaneous expression of moderately severe PAH in mice during air breathing. Although not an exact model of idiopathic PAH, the VIP-/- mouse should be useful for studying molecular mechanisms of PAH and evaluating potential therapeutic agents. VIP replacement therapy holds promise for the treatment of PAH, and mutations of the VIP gene may be a factor in the pathogenesis of idiopathic PAH.


Subject(s)
Blood Pressure/genetics , Hypertension, Pulmonary/genetics , Pulmonary Artery/pathology , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/genetics , Animals , Blood Pressure/drug effects , Disease Models, Animal , Disease Progression , Female , Gene Expression Profiling , Gene Targeting , Hypertension, Pulmonary/drug therapy , Hypertension, Pulmonary/pathology , Hypertrophy, Right Ventricular/drug therapy , Hypertrophy, Right Ventricular/genetics , Hypertrophy, Right Ventricular/physiopathology , Lung/blood supply , Lung/pathology , Male , Mice , Mice, Knockout , Pulmonary Artery/diagnostic imaging , Pulmonary Artery/drug effects , Survival Rate , Ultrasonography , Vasoactive Intestinal Peptide/therapeutic use , Ventricular Remodeling/drug effects , Ventricular Remodeling/genetics
9.
BMC Neurosci ; 9: 63, 2008 Jul 10.
Article in English | MEDLINE | ID: mdl-18616823

ABSTRACT

BACKGROUND: The neuropeptide vasoactive intestinal peptide (VIP) is widely distributed in the adult central nervous system where this peptide functions to regulate synaptic transmission and neural excitability. The expression of VIP and its receptors in brain regions implicated in learning and memory functions, including the hippocampus, cortex, and amygdala, raise the possibility that this peptide may function to modulate learned behaviors. Among other actions, the loss of VIP has a profound effect on circadian timing and may specifically influence the temporal regulation of learning and memory functions. RESULTS: In the present study, we utilized transgenic VIP-deficient mice and the contextual fear conditioning paradigm to explore the impact of the loss of this peptide on a learned behavior. We found that VIP-deficient mice exhibited normal shock-evoked freezing behavior and increases in corticosterone. Similarly, these mutant mice exhibited no deficits in the acquisition or recall of the fear-conditioned behavior when tested 24-hours after training. The VIP-deficient mice exhibited a significant reduction in recall when tested 48-hours or longer after training. Surprisingly, we found that the VIP-deficient mice continued to express circadian rhythms in the recall of the training even in those individual mice whose wheel running wheel activity was arrhythmic. One mechanistic explanation is suggested by the finding that daily rhythms in the expression of the clock gene Period2 continue in the hippocampus of VIP-deficient mice. CONCLUSION: Together these data suggest that the neuropeptide VIP regulates the recall of at least one learned behavior but does not impact the circadian regulation of this behavior.


Subject(s)
Cell Cycle Proteins/physiology , Circadian Rhythm/physiology , Cognition/physiology , Nuclear Proteins/physiology , Transcription Factors/physiology , Vasoactive Intestinal Peptide/physiology , Animals , Behavior, Animal/physiology , Brain/metabolism , Brain/physiology , Cell Cycle Proteins/genetics , Corticosterone/blood , Hippocampus/metabolism , Hippocampus/physiology , In Situ Hybridization , Learning/physiology , Memory/physiology , Memory, Short-Term/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Motor Activity/physiology , Nuclear Proteins/genetics , Period Circadian Proteins , RNA, Messenger/genetics , RNA, Messenger/metabolism , Receptors, Vasoactive Intestinal Peptide, Type II/physiology , Suprachiasmatic Nucleus/metabolism , Suprachiasmatic Nucleus/physiology , Synaptic Transmission/physiology , Transcription Factors/genetics , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/genetics
10.
Int J Dev Neurosci ; 26(5): 423-34, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18423945

ABSTRACT

Pharmacological studies indicate that vasoactive intestinal peptide (VIP) may be necessary for normal embryonic development in the mouse. For example, VIP antagonist treatment before embryonic day 11 resulted in developmental delays, growth restriction, modified adult brain chemistry and reduced social behavior. Here, developmental milestones, growth, and social behaviors of neonates of VIP-deficient mothers (VIP +/-) mated to VIP +/- males were compared with the offspring of wild type mothers (VIP +/+) mated to VIP +/+ and +/- males, to assess the contributions of both maternal and offspring VIP genotype. Regardless of their own genotype, all offsprings of VIP-deficient mothers exhibited developmental delays. No delays were seen in the offspring of wild type mothers, regardless of their own genotype. Body weights were significantly reduced in offspring of VIP-deficient mothers, with VIP null (-/-) the most affected. Regardless of genotype, all offspring of VIP-deficient mothers expressed reduced maternal affiliation compared with wild type offspring of wild type mothers; +/- offspring of wild type mothers did not differ in maternal affiliation from their wild type littermates. Play behavior was significantly reduced in all offsprings of VIP-deficient mothers. Maternal behavior did not differ between wild type and VIP-deficient mothers, and cross-fostering of litters did not change offspring development, indicating that offspring deficits were induced prenatally. This study illustrated that the VIP status of a pregnant mouse had a greater influence on the growth, development and behavior of her offspring than the VIP genotype of the offspring themselves. Deficiencies were apparent in +/+, +/- and -/- offspring born to VIP-deficient mothers; no deficiencies were apparent in +/- offspring born to normal mothers. These results underscore the significant contribution of the uterine environment to normal development and indicate a potential usefulness of the VIP knockout mouse in furthering the understanding of neurodevelopmental disorders with social behavior deficits such as autism.


Subject(s)
Behavior, Animal/physiology , Social Behavior , Vasoactive Intestinal Peptide/physiology , Analysis of Variance , Animals , Body Weight/genetics , Body Weight/physiology , Female , Genotype , Male , Mice , Mice, Knockout , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/genetics
11.
Exp Neurol ; 293: 62-73, 2017 07.
Article in English | MEDLINE | ID: mdl-28359740

ABSTRACT

Vasoactive intestinal peptide (VIP) is one of the neuropeptides showing the strongest up-regulation in the nociceptive pathway after peripheral nerve injury and has been proposed to support neuropathic pain. Nevertheless, the story may be more complicated considering the known suppressive effects of the peptide on the immune reactivity of microglial cells, which have been heavily implicated in the onset and maintenance of pain after nerve injury. We here used mice deficient in VIP and the model of spared nerve injury, characterized by persistent tactile hypersensitivity. While tactile hypersensitivity developed similarly to wild type mice for the ipsilateral hindpaw, only transgenic mice showed a mirror-image tactile hypersensitivity in the contralateral hindpaw. This exacerbated neuropathic pain phenotype appeared to be mediated through a local mechanism acting at the level of the lumbar spinal cord as a distant nerve lesion in the front limb did not lead to hindpaw hypersensitivity in VIP-deficient mice. Innocuous tactile hindpaw stimulation was found to increase a neuronal activation marker in the bilateral superficial laminae of the lumbar dorsal horn of VIP-deficient, but not wild type mice, after SNI. A deeper study into the immune responsiveness to the nerve lesion also proved that VIP-deficient mice had a stronger early pro-inflammatory cytokine response and a more pronounced microglial reactivity compared to wild type controls. The latter was also observed at four weeks after spared nerve injury, a time at which bilateral tactile hypersensitivity persisted in VIP-deficient mice. These data suggest an action of VIP in neuropathic states that is more complicated than previously assumed. Future research is now needed for a deeper understanding of the relative contribution of receptors and fiber populations involved in the VIP-neuropathic pain link.


Subject(s)
Hyperalgesia/etiology , Hyperalgesia/genetics , Neurogenic Inflammation/etiology , Neurogenic Inflammation/genetics , Peripheral Nerve Injuries/complications , Vasoactive Intestinal Peptide/deficiency , Animals , Calcium-Binding Proteins/metabolism , Cytokines/metabolism , Disease Models, Animal , Female , Functional Laterality/genetics , Gene Expression Regulation/genetics , Glial Fibrillary Acidic Protein/metabolism , Hyperalgesia/metabolism , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Microfilament Proteins/metabolism , Neuralgia/etiology , Neurogenic Inflammation/metabolism , Pain Measurement , Proto-Oncogene Proteins c-fos/metabolism , Time Factors , Vasoactive Intestinal Peptide/genetics
12.
Ann N Y Acad Sci ; 1070: 5-9, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16888146

ABSTRACT

We have taken advantage of the availability of vasoactive intestinal polypeptide (VIP) knockout (KO) mice to examine the possible influence of deletion of the VIP gene on: (a) airway reactivity and airway inflammation, as indicators of bronchial asthma; (b) mortality from endotoxemia, a model of septic shock; and (c) the pulmonary circulation. VIP KO mice showed: (a) airway hyperresponsiveness to the cholinergic agonist methacholine, as well as peribronchial and perivascular inflammation; (b) a greater susceptibility to death from endotoxemia; and (c) evidence suggestive of pulmonary hypertension.


Subject(s)
Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/metabolism , Animals , Bronchitis/chemically induced , Bronchitis/genetics , Bronchitis/metabolism , Disease Susceptibility , Endotoxemia/genetics , Endotoxemia/metabolism , Endotoxemia/pathology , Female , Lipopolysaccharides/pharmacology , Male , Methacholine Chloride/pharmacology , Mice , Mice, Inbred C57BL , Mice, Knockout , Survival Rate , Vasoactive Intestinal Peptide/genetics
13.
J Neurosci Methods ; 153(2): 214-20, 2006 Jun 15.
Article in English | MEDLINE | ID: mdl-16406043

ABSTRACT

Standard noninvasive recordings of the auditory brainstem evoked response (ABR) from a single pair of obliquely oriented electrodes (typically midline vertex referenced to mastoid) confound inherently distinct signals propagating over peripheral and central neural pathways differing in location and spatial orientation. We describe here a technique for recording short-latency auditory evoked potentials that putatively differentiates peripheral and central neural activity in the mouse and rat. The technique involves recording from two orthogonally oriented electrode pairs using fast sample rates (100 k/s) to accurately measure differences in neural timing and waveform morphology. Electrodes oriented in a transverse plane (mastoid-to-mastoid) register an initial positive-going ABR peak (P1T) earlier than a series of peaks recorded from electrodes oriented along the midline (anterior and posterior to the inter-aural line). The absolute P1T latency is consistent with an origin in the primary auditory nerve, while the delayed midline latencies implicate activity farther along central neural pathways. Differences between these latencies (midline minus transverse) provide new and precise measures of central conduction time (CCT), which in one case is as brief as 0.10 ms. Results in wild type (WT) and knockout (KO) mice, as well as rats, show significant differences in absolute latencies as well as CCT.


Subject(s)
Central Nervous System/physiology , Electrodes , Evoked Potentials, Auditory, Brain Stem/physiology , Neural Pathways/physiology , Peripheral Nerves/physiology , Acoustic Stimulation/methods , Animals , Animals, Newborn , Electroencephalography/methods , Electronic Data Processing , Evoked Potentials, Auditory, Brain Stem/genetics , Heart Rate/physiology , Heart Rate/radiation effects , Mice , Mice, Knockout , Neural Pathways/radiation effects , Pituitary Adenylate Cyclase-Activating Polypeptide/deficiency , Rats , Reaction Time/physiology , Vasoactive Intestinal Peptide/deficiency
14.
PLoS One ; 10(5): e0125225, 2015.
Article in English | MEDLINE | ID: mdl-25932952

ABSTRACT

Inflammatory bowel disease is a chronic gastrointestinal inflammatory disorder associated with changes in neuropeptide expression and function, including vasoactive intestinal peptide (VIP). VIP regulates intestinal vasomotor and secretomotor function and motility; however, VIP's role in development and maintenance of colonic epithelial barrier homeostasis is unclear. Using VIP deficient (VIPKO) mice, we investigated VIP's role in epithelial barrier homeostasis, and susceptibility to colitis. Colonic crypt morphology and epithelial barrier homeostasis were assessed in wildtype (WT) and VIPKO mice, at baseline. Colitic responses were evaluated following dinitrobenzene sulfonic acid (DNBS) or dextran-sodium sulfate (DSS) exposure. Mice were also treated with exogenous VIP. At baseline, VIPKO mice exhibited distorted colonic crypts, defects in epithelial cell proliferation and migration, increased apoptosis, and altered permeability. VIPKO mice also displayed reduced goblet cell numbers, and reduced expression of secreted goblet cell factors mucin 2 and trefoil factor 3. These changes were associated with reduced expression of caudal type homeobox 2 (Cdx2), a master regulator of intestinal function and homeostasis. DNBS and DSS-induced colitis were more severe in VIPKO than WT mice. VIP treatment rescued the phenotype, protecting VIPKO mice against DSS colitis, with results comparable to WT mice. In conclusion, VIP plays a crucial role in the development and maintenance of colonic epithelial barrier integrity under physiological conditions and promotes epithelial repair and homeostasis during colitis.


Subject(s)
Colitis/prevention & control , Homeostasis/drug effects , Intestines/pathology , Protective Agents/pharmacology , Vasoactive Intestinal Peptide/metabolism , Animals , CDX2 Transcription Factor , Cell Count , Colitis/pathology , Dinitrofluorobenzene/analogs & derivatives , Disease Susceptibility , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Goblet Cells/pathology , Homeodomain Proteins/metabolism , Intestines/drug effects , Male , Mice, Inbred C57BL , Mice, Knockout , Real-Time Polymerase Chain Reaction , Signal Transduction/drug effects , Transcription Factors/metabolism , Vasoactive Intestinal Peptide/deficiency
15.
Biol Psychiatry ; 39(2): 82-91, 1996 Jan 15.
Article in English | MEDLINE | ID: mdl-8717605

ABSTRACT

Neuropeptide concentrations were determined in the postmortem cerebral cortex from 19 cognitive-impaired schizophrenics, 4 normal elderly subjects, 4 multi-infarct dementia (MID) cases, and 13 Alzheimer's disease (AD) patients. Only AD patients met criteria for AD. The normal elderly and MID cases were combined into one control group. Somatostatin concentrations were reduced in both schizophrenia and AD. Neuropeptide Y concentrations were reduced only in schizophrenia, and corticotropin-releasing hormone concentrations were primarily reduced in AD. Concentrations of vasoactive intestinal polypeptide and cholecystokinin also were reduced in schizophrenia, although not as profoundly as somatostatin or neuropeptide Y. In AD, cholecystokinin and vasoactive intestinal peptide were unchanged. Neuropeptide deficits in schizophrenics were more pronounced in the temporal and frontal lobes than in the occipital lobe. The mechanisms underlying these deficits in schizophrenia and AD are likely distinct. In schizophrenia, a common neural element, perhaps the cerebral cortical gaba-aminobutyric acid (GABA)-containing neuron, may underlie these deficits.


Subject(s)
Alzheimer Disease/metabolism , Cerebral Cortex/metabolism , Cognition , Neuropeptides/deficiency , Schizophrenia/metabolism , Aged , Aged, 80 and over , Autopsy , Case-Control Studies , Cholecystokinin/deficiency , Corticotropin-Releasing Hormone/deficiency , Dementia, Multi-Infarct/metabolism , Female , Frontal Lobe/metabolism , Humans , Male , Occipital Lobe/metabolism , Schizophrenic Psychology , Somatostatin/deficiency , Temporal Lobe/metabolism , Vasoactive Intestinal Peptide/deficiency
16.
PLoS One ; 8(5): e61449, 2013.
Article in English | MEDLINE | ID: mdl-23700405

ABSTRACT

RATIONALE: Vasoactive Intestinal Peptide (VIP), a pulmonary vasodilator and inhibitor of vascular smooth muscle proliferation, is absent in pulmonary arteries of patients with idiopathic pulmonary arterial hypertension (PAH). We previously determined that targeted deletion of the VIP gene in mice leads to PAH with pulmonary vascular remodeling and right ventricular (RV) dilatation. Whether the left ventricle is also affected by VIP gene deletion is unknown. In the current study, we examined if VIP knockout mice (VIP(-/-)) develop both right (RV) and left ventricular (LV) cardiomyopathy, manifested by LV dilatation and systolic dysfunction, as well as overexpression of genes conducive to heart failure. METHODS: We examined VIP(-/-)and wild type (WT) mice using Magnetic Resonance Imaging (MRI) for evidence of cardiomyopathy associated with biventricular dilation and wall thickness changes. Lung tissue from VIP(-/-) and WT mice was subjected to whole-genome gene microarray analysis. RESULTS: Lungs from VIP(-/-) mice showed overexpression of cardiomyopathy genes: Myh1 was upregulated 224 times over WT, and Mylpf was increased 72 fold. Tnnt3 was increased 105 times and tnnc2 181 fold. Hearts were dilated in VIP(-/-) mice, with thinning of LV wall and increase in RV and LV chamber size, though RV enlargement varied. Weights of VIP(-/-) mice were consistently lower. CONCLUSIONS: Critically-important heart failure-related genes are upregulated in VIP(-/-) mice associated with the spontaneous cardiomyopathy phenotype, involving both left and right ventricles, suggesting that loss of the VIP gene orchestrates a panoply of pathogenic genes which are detrimental to both left and right cardiac homeostasis.


Subject(s)
Cardiomyopathies/genetics , Heart Failure/genetics , Up-Regulation , Vasoactive Intestinal Peptide/genetics , Animals , Cardiomyopathies/metabolism , Cardiomyopathies/physiopathology , Female , Gene Deletion , Heart Failure/metabolism , Heart Failure/physiopathology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Oligonucleotide Array Sequence Analysis , Phenotype , Stroke Volume/genetics , Transcriptome , Vasoactive Intestinal Peptide/deficiency
17.
Neuron ; 78(5): 799-806, 2013 Jun 05.
Article in English | MEDLINE | ID: mdl-23764285

ABSTRACT

Systems of coupled oscillators abound in nature. How they establish stable phase relationships under diverse conditions is fundamentally important. The mammalian suprachiasmatic nucleus (SCN) is a self-sustained, synchronized network of circadian oscillators that coordinates daily rhythms in physiology and behavior. To elucidate the underlying topology and signaling mechanisms that modulate circadian synchrony, we discriminated the firing of hundreds of SCN neurons continuously over days. Using an analysis method to identify functional interactions between neurons based on changes in their firing, we characterized a GABAergic network comprised of fast, excitatory, and inhibitory connections that is both stable over days and changes in strength with time of day. By monitoring PERIOD2 protein expression, we provide the first evidence that these millisecond-level interactions actively oppose circadian synchrony and inject jitter into daily rhythms. These results provide a mechanism by which circadian oscillators can tune their phase relationships under different environmental conditions.


Subject(s)
Circadian Rhythm/physiology , Nerve Net/physiology , Neurons/physiology , Periodicity , gamma-Aminobutyric Acid/metabolism , Action Potentials/genetics , Animals , Brain Mapping , Circadian Rhythm/genetics , Colchicine/pharmacology , GABA Antagonists/pharmacology , Luciferases/genetics , Luminescent Measurements , Mice , Mice, Transgenic , Nerve Net/drug effects , Neural Inhibition/drug effects , Neural Inhibition/genetics , Organ Culture Techniques , Patch-Clamp Techniques , Period Circadian Proteins/genetics , Pyridazines/pharmacology , Signal Transduction/drug effects , Signal Transduction/genetics , Suprachiasmatic Nucleus/cytology , Time Factors , Tubulin Modulators/pharmacology , Vasoactive Intestinal Peptide/deficiency
18.
J Mol Neurosci ; 48(3): 744-56, 2012 Nov.
Article in English | MEDLINE | ID: mdl-22865090

ABSTRACT

These studies examined the transcriptional and translational plasticity of three transient receptor potential (TRP) channels (TRPA1, TRPV1, TRPV4) with established neuronal and non-neuronal expression and functional roles in the lower urinary tract. Mechanosensor and nociceptor roles in either physiological or pathological lower urinary tract states have been suggested for TRPA1, TRPV1, and TRPV4. We have previously demonstrated the neurochemical, organizational, and functional plasticity in micturition reflex pathways following induction of urinary bladder inflammation using the antineoplastic agent, cyclophosphamide. More recently, we have characterized similar plasticity in micturition reflex pathways in a transgenic mouse model with chronic urothelial overexpression (OE) of nerve growth factor (NGF) and in a transgenic mouse model with deletion of vasoactive intestinal polypeptide (VIP). In addition, the micturition reflex undergoes postnatal maturation that may also reflect plasticity in urinary bladder TRP channel expression. Thus, we examined plasticity in urinary bladder TRP channel expression in diverse contexts using a combination of quantitative, real-time PCR and western blotting approaches. We demonstrate transcriptional and translational plasticity of urinary bladder TRPA1, TRPV1, and TRVP4 expression. Although the functional significance of urinary bladder TRP channel plasticity awaits further investigation, these studies demonstrate context- (inflammation, postnatal development, NGF-OE, VIP deletion) and tissue-dependent (urothelium + suburothelium, detrusor) plasticity.


Subject(s)
Cystitis/metabolism , Gene Expression Regulation/physiology , Muscle, Smooth/metabolism , Nerve Growth Factor/physiology , Urinary Bladder/metabolism , Urination/physiology , Urothelium/metabolism , Aging/physiology , Animals , Cyclophosphamide/toxicity , Cystitis/chemically induced , Cystitis/genetics , Cystitis/physiopathology , Disease Progression , Female , Mice , Mice, Knockout , Mice, Transgenic , Nerve Growth Factor/biosynthesis , Nerve Growth Factor/genetics , Organ Specificity , Protein Biosynthesis , Rats , Rats, Wistar , Recombinant Fusion Proteins/biosynthesis , Recombinant Fusion Proteins/physiology , Reflex, Abnormal , Transcription, Genetic , Urinary Bladder/growth & development , Urinary Bladder/physiopathology , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/genetics
19.
PLoS One ; 7(5): e36922, 2012.
Article in English | MEDLINE | ID: mdl-22615845

ABSTRACT

Vasoactive intestinal peptide (VIP) is a pleiotropic neuropeptide with immunomodulatory properties. The administration of this peptide has been shown to have beneficial effects in murine models of inflammatory diseases including septic shock, rheumatoid arthritis, multiple sclerosis (MS) and Crohn's disease. However, the role of the endogenous peptide in inflammatory disease remains obscure because VIP-deficient mice were recently found to exhibit profound resistance in a model of MS. In the present study, we analyzed the response of female VIP deficient (KO) mice to intraperitoneal lipopolysaccharide (LPS) administration. We observed significant resistance to LPS in VIP KO mice, as evidenced by lower mortality and reduced tissue damage. The increased survival was associated with decreased levels of proinflammatory cytokines (TNFα, IL-6 and IL-12) in sera and peritoneal suspensions of these mice. Moreover, the expression of TNFα and IL-6 mRNA was reduced in peritoneal cells, spleens and lungs from LPS-treated VIP KO vs. WT mice, suggesting that the resistance might be mediated by an intrinsic defect in the responsiveness of immune cells to endotoxin. In agreement with this hypothesis, peritoneal cells isolated from VIP KO naive mice produced lower levels of proinflammatory cytokines in response to LPS in vitro. Finally, decreased NF-κB pathway activity in peritoneal cells was observed both in vivo and in vitro, as determined by assay of phosphorylated I-κB. The results demonstrate that female VIP KO mice exhibit resistance to LPS-induced shock, explainable in part by the presence of an intrinsic defect in the responsiveness of inflammatory cells to endotoxin.


Subject(s)
Endotoxemia/immunology , Inflammation Mediators/immunology , Inflammation/immunology , Lipopolysaccharides/pharmacology , Neuropeptides/immunology , Vasoactive Intestinal Peptide/deficiency , Vasoactive Intestinal Peptide/immunology , Animals , Endotoxemia/chemically induced , Endotoxins/administration & dosage , Endotoxins/immunology , Female , Inflammation/blood , Inflammation/genetics , Inflammation/metabolism , Interleukin-12/blood , Interleukin-12/immunology , Interleukin-6/blood , Interleukin-6/immunology , Lipopolysaccharides/immunology , Lung/immunology , Lung/metabolism , Mice , Mice, Inbred C57BL , NF-kappa B/immunology , NF-kappa B/metabolism , Neuropeptides/genetics , RNA, Messenger/genetics , RNA, Messenger/immunology , Spleen/immunology , Spleen/metabolism , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/immunology , Vasoactive Intestinal Peptide/genetics
20.
J Biol Rhythms ; 25(4): 235-46, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20679493

ABSTRACT

Daily exercise promotes physical health as well as improvements in mental and neural functions. Studies in intact wild-type (WT) rodents have revealed that the brain's suprachiasmatic nuclei (SCN), site of the main circadian pacemaker, are also responsive to scheduled wheel running. It is unclear, however, if and how animals with a dysfunctional circadian pacemaker respond to exercise. Here, we tested whether scheduled voluntary exercise (SVE) in a running wheel for 6 hours per day could promote neural and behavioral rhythmicity in animals whose circadian competence is compromised through genetically targeted loss of vasoactive intestinal polypeptide (VIP(-/-) mice) or its VPAC(2) receptor (Vipr2(-/-) mice). We report that in constant dark (DD), rhythmic VIP(-/-) and Vipr2(-/-) mice show weak free-running rhythms with a period of <23 hours and all wild-type mice are strongly rhythmic with approximately 23.5-hour periodicity. VIP(-/-) and Vipr2(-/-) mice rapidly (<7 days) synchronize to daily SVE, while WT mice take much longer (>35 days). Following 21 to 50 days of SVE, WT mice show small changes in their rhythms, and most Vipr2(-/-) mice now sustain robust near 24-hour behavioral rhythms, whereas very few VIP(-/-) mice do. This study demonstrates that scheduled daily exercise can markedly improve circadian rhythms in behavioral activity and raises the possibility that this noninvasive approach may be useful as an intervention in clinical etiologies in which there are dysfunctions of circadian time keeping.


Subject(s)
Circadian Rhythm/genetics , Motor Activity/physiology , Receptors, Vasoactive Intestinal Peptide, Type II/deficiency , Vasoactive Intestinal Peptide/deficiency , Animals , Circadian Rhythm/physiology , Darkness , Mice , Proto-Oncogene Proteins c-fos/biosynthesis , Suprachiasmatic Nucleus/physiology
SELECTION OF CITATIONS
SEARCH DETAIL